Trial intelligence / Profile preview

Effect of albumin infusion on oxidative albumin modification and plasma thiol status

2016-004012-35Phase 4Active

Sponsor
Medical University of Graz
Start
Dec 2016
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of albumin (human) in hepatorenal syndrome (HRS), primary peritonitis, ascites, sponsored by Medical University of Graz. Started Dec 2016; status: active.

02

Drugs

albumin (human)
03

Conditions

hepatorenal syndrome (HRS)primary peritonitisascites

Beyond the preview

Go deeper on 2016-004012-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-004012-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call